
Nate Silver @NateSilver538
Why was AstraZeneca so slow to recruit older people for its trials? Seems like a dumb strategy for a pandemic that is much deadlier among older people. (More context at this link: https://t.co/R0PNv2w6Gf) — PolitiTweet.org
Oliver Moody @olivernmoody
Here it is: the crucial table showing Germany's calculations on the AstraZeneca vaccine's efficacy in over-65s. And… https://t.co/XmGCwKDnS8